Back
EyePoint Pharmaceuticals 10K Form
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.30
Seasonality Move:
7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EYPT News And Ratings
See the #1 stock for the next 7 days that we like better than EYPT
EYPT Financial Statistics
Sales & Book Value
Annual Sales: | $46M |
---|---|
Cash Flow: | $-40.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.09 |
Price / Book: | 2.22 |
Profitability
EPS (TTM): | -1.99000 |
---|---|
Net Income (TTM): | $-103.6M |
Gross Margin: | $41.4M |
Return on Equity: | -50.67% |
Return on Assets: | -35.24% |
EyePoint Pharmaceuticals Earnings Forecast
Key EyePoint Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 16 years for EYPT is 89.93%.
-
The Selling, General & Administrative Expenses for EYPT have been equal to 112.55% of Gross Profit Margin.
-
The Research & Development expenses have been 140.51% of Revenue.
-
The Interest Expense is -1.76% of Operating Income.
-
The Net Earning history of EYPT is -153.84% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 10 years.
EyePoint Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | EYPT |
CUSIP: | 30233G |
Website: | eyepointpharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.5 |
Quick Ratio: | 5.21 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
EYPT Technical Analysis vs Fundamental Analysis
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.